2008•Journal of Clinical ImmunologyRequires access

Serum Levels of IL-17 and IL-22 Are Reduced by Etanercept, but not by Acitretin, in Patients with Psoriasis: a Randomized-Controlled Trial

Marzia Caproni, Emiliano Antiga, Lucilla Melani, Walter Volpi, Elena Del Bianco, Paolo Fabbri

Open publisher page 179 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 179 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Acitretin, Etanercept, Psoriasis, Psoriasis Area and Severity Index, Medicine, Randomized controlled trial, Interleukin 17, Dermatology

Back to paper search Browse research topics Original source

Serum Levels of IL-17 and IL-22 Are Reduced by Etanercept, but not by Acitretin, in Patients with Psoriasis: a Randomized-Controlled Trial — Research Paper | ScholarLens